Skip to main content

REPROCELL Becomes VIP Supplier on Biotech Marketplace

Beltsville, USA: REPROCELL, an industry leader in the use of human biospecimens for medical research, has partnered with, the healthcare industry’s leading marketplace for life science research, to bring its services to the global biotechnology community. REPROCELL joins a select group of highly-rated marketplace VIP suppliers that commit to outstanding customer service and offer a discount to biotech customers.

“Over the past 6 years, has helped make our services available to thousands of pre-qualified pharmaceutical researchers, “stated Daisuke Usui, COO of REPROCELL. “We are pleased to join their new biotech marketplace as a VIP supplier and expand our access to biotech researchers as well.”

“REPROCELL offers a broad combination of expertise that can be applied to nearly the entire drug discovery pipeline, including human tissue acquisition, iPSC reprogramming, cell differentiation, in vitro tissue modelling with 3D technology and complex assay development,” said Kevin Lustig, PhD, CEO and Founder of “They have consistently received excellent customer ratings and reviews on our pharmaceutical marketplace. As a VIP supplier on our new biotech marketplace, their top-rated services are now available at a discount to biotech researchers.”

To browse all available services or initiate an order, visit the REPROCELL profile page on the marketplace.

About REPROCELL: REPROCELL is the leading human-tissue CRO and was one of the first companies to commercialize iPSCs globally. The company is passionate about better translating scientific discoveries into therapies, offering an extensive portfolio of translational services and products. REPROCELL is also home to the worlds most extensive human tissue biorepository and can design custom, end-to-end research studies to meet your unique research needs.

About is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk and provides access to the latest innovative tools and technologies. operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 80 biotechnology companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH).  Visit to learn more.

Join on social media: LinkedInTwitterYouTubeFacebook and Instagram


Subscribe to receive updates from REPROCELL